NCT02133261

Brief Summary

The purpose of this research study is to learn if a new 7 day patch ECG recording monitor can serve the same purpose as standard monitoring systems. The new 7day patch is significantly smaller and lighter than previous ECG recorders.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jun 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 6, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 8, 2014

Completed
24 days until next milestone

Study Start

First participant enrolled

June 1, 2014

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2014

Completed
Last Updated

June 26, 2014

Status Verified

June 1, 2014

Enrollment Period

Same day

First QC Date

May 6, 2014

Last Update Submit

June 25, 2014

Conditions

Outcome Measures

Primary Outcomes (1)

  • adhesive performance/durability

    The study will evaluate adhesive performance/durability by evaluating the Signal Quality of ECG data on the subjects (5 men and 5 women) in accordance with the requirements of FDA's ECG Electrode Guidance (section 5.A.3)1 and the ANSI/AAMI EC-12 Disposable ECG electrode technical standard (sections 4.4 and 5.4)2.

    7 days

Secondary Outcomes (1)

  • human factors

    7 days

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

cardiac patients followed at the study site's location

You may qualify if:

  • cardiac patient volunteers (5 male and 5 female)

You may not qualify if:

  • skin rash or infection over the sternum
  • Sternal incision within 3 months from the date of enrollment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

EvergreenHealth

Enumclaw, Washington, 98022, United States

Location

Study Officials

  • Gene Trobaugh, MD

    EvergreenHealth

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 6, 2014

First Posted

May 8, 2014

Study Start

June 1, 2014

Primary Completion

June 1, 2014

Study Completion

June 1, 2014

Last Updated

June 26, 2014

Record last verified: 2014-06

Locations